Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Antiplatelets
DRUG
3 trials
Sponsors
S. Andrea Hospital
, Sanofi
, Pfizer
Conditions
Acute Coronary Syndrome
Atrial Fibrillation
CADASIL
Hypercholesterolemia
Phase 2
Safety Study of Dabigatran in CADASIL
NCT01361763
S. Andrea Hospital
CADASIL
Start: 2011-06-30
End: 2015-02-28
Target: 50
Updated: 2014-02-11
Phase 4
Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
Completed
NCT02984982
Sanofi
Acute Coronary Syndrome, Hypercholesterolemia
Start: 2016-11-15
End: 2018-07-27
Updated: 2019-09-09
Unknown Phase
Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea
Completed
NCT03572972
Pfizer
Atrial Fibrillation
Start: 2018-01-31
End: 2018-12-20
Updated: 2023-04-06
Related Papers
Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea.
2022-05-07
3 citations
Effect of alirocumab on coronary atheroma volume in Japanese patients with acute coronary syndromes and hypercholesterolemia not adequately controlled with statins: ODYSSEY J-IVUS rationale and design.
2018-03-30
7 citations